Back
Bioventus Vs. Neurogene Industry Stock Comparison
Sell
36
BVS
Bioventus
Last Price:
$9.27
Seasonality Move:
-18.96%
Sell
1
NGNE
Neurogene
Last Price:
$19.46
Seasonality Move:
2.93%
Sell
36
Bioventus (BVS)
is a Sell
Is Bioventus a Buy, Sell or Hold?
-
BVS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BVS Stock Price Chart
BVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.5 | Sell |
Relative Strength Index (14 RSI): | 27.5 | Sell |
Chaikin Money Flow: | -76582 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.1 - 11.34) | Sell |
Bollinger Bands (100): | (10.12 - 12.46) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.97 | Sell |
Relative Strength Index (14 RSI): | 34.54 | Sell |
Chaikin Money Flow: | -115648 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.71 - 23.79) | Sell |
Bollinger Bands (100): | (23.43 - 49.31) | Sell |
BVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.05 | Sell |
20-day SMA: | 10.56 | Sell |
50-day SMA: | 11.39 | Sell |
200-day SMA: | 8.65 | Buy |
8-day EMA: | 9.92 | Sell |
20-day EMA: | 10.46 | Sell |
50-day EMA: | 10.97 | Sell |
200-day EMA: | 9.19 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.16 | Sell |
20-day SMA: | 22.7 | Sell |
50-day SMA: | 30.8 | Sell |
200-day SMA: | 36.82 | Sell |
8-day EMA: | 21.82 | Sell |
20-day EMA: | 23.14 | Sell |
50-day EMA: | 28.39 | Sell |
200-day EMA: | 33.59 | Sell |
Bioventus Earnings Growth & BVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.22 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.00 per share.
Bioventus Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |